Adamant Biomedical Investments »

Halozyme Therapeutics shares owned by Adamant Biomedical Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Adamant Biomedical Investments from 13F filings

Historical chart of Adamant Biomedical Investments investment in Halozyme Therapeutics

Oct 52014Oct 19Nov 2Nov 16Nov 30Dec 14Dec 28550k560k570k580k59.999k59.9995k60k60.0005k60.001k
Value ($)Share countHistorical HALO position of Adamant Biomedical Investments Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Adamant Biomedical Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Adamant Biomedical Investments

Quarter filed Position value Share count Share price at filing
2014-12-31 $579k 60k 9.65
2014-09-30 $546k 60k 9.10